Removing a breast implant does not always require removing the capsule. According to a 2024 consensus statement, en bloc capsulectomy is necessary only for patients with established or suspected implant-associated cancer. Volume loss and some degree of ptosis are expected after removal; a lift can be planned in the same session where appropriate.
There has been a clear shift internationally in recent years: more women are choosing to have their implants removed.
The reasons vary. Changing lifestyle, evolving aesthetic preference, or symptoms attributed to the implants themselves.
But the information available makes this decision considerably harder than it needs to be — particularly on one point: whether the capsule should be removed.
This article covers how the decision to explant is made, what the guidelines actually say about the capsule, how the breast looks afterwards, and what can be done in the same operation.
Why are implants removed?
| Reason | Explanation |
|---|---|
| Capsular contracture | Hardening of the tissue around the implant, distorting the breast |
| Implant rupture | Tearing or leakage of the implant |
| Malposition | Implant displacement, asymmetry |
| Change in aesthetic preference | Desire for a smaller or more natural appearance |
| Lifestyle | Sport, comfort, back and neck complaints |
| Systemic symptoms | Wide-ranging symptoms attributed to the implants |
| Suspected implant-associated cancer | Rare; requires separate assessment and oncological management |
The final row sits outside the scope of this article. Where implant-associated cancer is suspected, the pathway is oncological and follows a different protocol.
Systemic symptoms attributed to implants
This topic deserves careful handling.
Some women describe wide-ranging symptoms they attribute to their implants: fatigue, joint pain, difficulty concentrating, skin problems and many others. More than a hundred symptoms have been reported in the literature, with no consistent pattern identified.
Two things need saying together here.
First: these symptoms are real and affect quality of life. Some patients report improvement after their implants are removed.
Second: the science remains unsettled. In a comprehensive biospecimen study conducted by ASERF, no consistent, measurable differences were found between the symptomatic cohort and control cohorts across full blood count, thyroid levels, C-reactive protein, twelve different cytokines and antibodies to staphylococcal enterotoxins.
No measurable marker has been identified. That does not mean the symptoms are not real — it means the mechanism has not yet been demonstrated.
The reason for making this distinction is straightforward: a patient’s decision deserves respect, but no promise can be made that surgery will resolve the symptoms.
The capsule: the most widely misunderstood issue
A thin layer of scar tissue — the capsule — forms around every implant over time. It is a normal response to a foreign body and is present in every patient with implants.
The question is whether it should be removed along with the implant.
On social media and in much online content, one answer circulates: “en bloc is essential.” The guidelines say something different.
The terminology, clarified
Four distinct procedures are routinely conflated:
- Partial capsulectomy: removal of a portion of the capsule
- Total capsulectomy: removal of the entire capsule, not necessarily in one piece
- Total intact capsulectomy: removal of the capsule in one sealed piece
- En bloc capsulectomy: removal of the capsule with a margin of surrounding healthy tissue
In everyday use, “en bloc” is applied to all four. In surgical literature, however, en bloc is an oncological term carrying the margin principle of cancer surgery.
What do the guidelines say?
The 2024 Breast Surgery Collaborative Community consensus statement — which included representatives of the American Society of Plastic Surgeons and The Aesthetic Society — is explicit:
En bloc capsulectomy is necessary only in patients with established or, after appropriate workup, suspected implant-associated cancer.
The same statement notes that en bloc is a lengthy, complex and expensive procedure, unnecessary outside specific cases, capable of leaving significant breast deformity and prone to complications.
What does the evidence show?
This is not a matter of opinion. It has been measured.
In a prospective, blinded study conducted by ASERF, different capsulectomy types were compared in patients having implants removed for systemic symptoms. No difference in symptom improvement was found between limited capsule removal, partial capsulectomy and total en bloc capsulectomy.
A prospective study from the Netherlands produced an even more striking finding: 78% of participants had no capsule removed at all, and their symptom improvement was equivalent to those who underwent capsulectomy.
En bloc carries greater risk
This point is rarely discussed.
Removing the capsule in one piece with surrounding tissue is technically demanding, particularly with submuscular implants. The capsule must be separated from the ribs and costal cartilages, which risks injury to the intercostal muscles, and lung injury has been reported in the literature.
There is a further reality: en bloc is not possible in every patient. Where the capsule is very thin or adherent to the chest wall, it cannot be removed intact — and this cannot be established with certainty before surgery begins.
A guarantee of en bloc removal made before the operation is therefore not realistic. What matters is agreeing in advance how to proceed if it turns out not to be possible.
When is capsulectomy indicated?
- Capsular contracture
- Implant rupture, particularly with silicone leakage
- Calcification within the capsule
- Textured-surface implants
- Suspected implant-associated cancer
In the absence of these findings, removing the entire capsule lengthens the operation, increases risk and provides no demonstrated additional benefit.
How does the breast look afterwards?
Let us be realistic: the breast does not return to its pre-implant appearance.
- The skin has stretched. Skin that has carried implant volume for years does not fully retract when that volume is removed.
- Breast tissue has thinned. Pressure from the implant can thin the overlying tissue over time.
- You have aged. The years since the implants were placed have brought natural ageing too.
- Pregnancy, breastfeeding and weight changes may have occurred in the interim.
The expected picture is volume loss with varying degrees of ptosis. How pronounced depends on implant volume, duration in place, skin quality and existing breast tissue.
Some skin retraction occurs and takes months. The final appearance, however, differs in most patients from the pre-implant state.
Can a lift be done in the same session?
Yes, and it frequently is.
In a series of 248 patients undergoing implant removal with total capsulectomy, 21% had a mastopexy performed in the same session.
A lift reshapes the remaining breast tissue and removes excess skin, producing a fuller-looking result. It does not add volume — it reorganises what is there.
For volume, one further option exists: fat transfer. Fat harvested from elsewhere on the body can replace some of the lost volume. Not all transferred fat survives, however, and a second session may be needed.
Same session or staged?
A combined approach is not appropriate for every patient.
In some cases removing the implant first, allowing the tissue to settle, and reshaping in a second procedure produces a safer result — particularly after extensive capsulectomy where tissue perfusion may be compromised.
The decision follows tissue quality and intraoperative findings.
Recovery
- First days: swelling, bruising and tenderness. Drains may be used if capsulectomy was performed.
- Weeks 1-2: most swelling subsides; return to desk-based work usually possible.
- Weeks 3-6: graduated return to normal activity.
- Months 3-6: skin retraction and shape beginning to settle.
- Months 6-12: final appearance; scars continue to mature.
Recovery takes somewhat longer in patients who had capsulectomy, as the procedure is more extensive.
Travelling for surgery
Two points deserve specific planning for international patients.
First, the surgical plan cannot be fully determined in advance. Whether the capsule needs removing, whether it can be removed intact, and whether a lift is appropriate all depend partly on findings during surgery. Arriving with a fixed expectation of a specific technique makes the process harder rather than easier.
Second, bring your implant records if you have them — manufacturer, type, surface, volume and date of placement. Textured implants in particular change the assessment, and this information is not always retrievable from imaging alone.
The timing of return travel is confirmed by the treating surgeon based on your recovery, and tends to be slightly longer where capsulectomy has been performed.
Questions worth asking
- Is there a medical indication for removal in my case, or is this preference?
- Does my capsule need removing, and if so, why?
- How will we proceed if en bloc is not possible?
- What will my breast look like afterwards?
- Can a lift be done in the same session, and should it be?
- What are the options for volume loss?
- Where will the scars be?
Question three matters and is rarely asked. Question two is the most decisive: “everyone gets en bloc” is not consistent with the guidelines, and whether there is a valid indication in your specific case should be discussed openly.
In summary
Implant removal is a valid decision, whether prompted by medical indication or personal preference.
On the capsule, current guidelines are clear: en bloc capsulectomy is necessary only where implant-associated cancer is established or suspected. In patients having implants removed for systemic symptoms, no difference in symptom improvement has been demonstrated between capsulectomy types.
Capsulectomy is indicated for specific findings — contracture, rupture, calcification, textured implants. Without these, removing the entire capsule lengthens the operation and increases risk.
As for the result: the breast does not return to its pre-implant appearance. Volume loss and ptosis are expected, and reshaping through a lift or fat transfer can be planned where appropriate.
If you would like your own situation assessed and an appropriate plan discussed, you can arrange a consultation. Related procedures are outlined on the breast lift page.
Frequently Asked Questions
Does the capsule have to be removed with the implant?
Not always. Capsulectomy is indicated for capsular contracture, rupture, calcification, textured implants and suspected cancer. Without these findings it provides no demonstrated additional benefit.
Is en bloc capsulectomy essential?
No. According to the 2024 consensus statement, en bloc capsulectomy is necessary only in patients with established or suspected implant-associated cancer. The same statement notes it can leave significant breast deformity and is prone to complications.
Will my symptoms persist if the capsule is left in place?
The evidence does not support that. In ASERF’s prospective, blinded study, no difference in symptom improvement was found between capsulectomy types. In a Dutch study, 78% of participants had no capsule removed and showed equivalent improvement.
Can en bloc be performed in every patient?
No. Where the capsule is very thin or adherent to the chest wall it cannot be removed intact, and this cannot be established before surgery begins. A guarantee made in advance is not realistic.
Will my breast return to how it looked before implants?
No. Skin that has carried implant volume for years does not fully retract. Volume loss and varying degrees of ptosis are expected findings.
Can a lift be performed at the same time?
Frequently yes. In a series of 248 patients, 21% had a mastopexy in the same session. In some patients, however, staging the reshaping is safer.
Can lost volume be replaced?
Fat transfer is one option. Not all transferred fat survives, and a second session may be needed.
How long is recovery?
Most swelling subsides within 1-2 weeks, with graduated return to normal activity over 3-6 weeks. Shape settles over 3-6 months and the final appearance emerges between 6 and 12 months.
Dr. Ahmet Kaplan — Specialist in Plastic, Reconstructive and Aesthetic Surgery. A graduate of Hacettepe University Faculty of Medicine, he obtained his specialist title in 2020 and passed the European Board of Plastic, Reconstructive and Aesthetic Surgery (EBOPRAS) examination in 2022. Based in Istanbul. About Dr. Kaplan
This content is for informational purposes only and does not replace medical examination, diagnosis or treatment. Results vary between individuals.
References
- Breast Surgery Collaborative Community. Consensus Statement on Breast Implant Capsulectomy Definitions and Management, 2024.
- Glicksman C, McGuire P, Kadin M, et al. Impact of Capsulectomy Type on Post-Explantation Systemic Symptom Improvement. Aesthetic Surgery Journal 2021.
- Outcomes of Implant Removal and Capsulectomy for Breast Implant Illness. PRS Global Open 2021 (248 patients).
- The Aesthetic Society. Patient Safety Advisory — Breast Implant Removal and Capsulectomy.
